Journal of Hematology
Overview
Journal of Hematology is a scientific journal, published since 2012 in English. The journal's country of origin is Canada and its primary focus area is hematology.
Details
Details
Abbr.
J Hematol
Start
2012
End
Continuing
Frequency
Quarterly, 2014-
p-ISSN
1927-1212
e-ISSN
1927-1220
Country
Canada
Language
English
Specialty
Hematology
Recent Articles
1.
Aleem A, Algahtani F, Alzahrani M, Jamal A, Alsaleh K, Sewaralthahab S, et al.
J Hematol
. 2025 Feb;
14(1):14-19.
PMID: 39935703
Background: The incidence of central nervous system (CNS) relapse in diffuse large B-cell lymphoma (DLBCL) varies, and the optimum strategy of CNS prophylaxis remains to be defined. We aimed to...
2.
Al-Jefri A, Siddiqui K, Al-Ghadeer B, Al-Seraihy A, Al-Ahmari A, Ghemlas I, et al.
J Hematol
. 2025 Feb;
14(1):26-31.
PMID: 39935702
Background: Graft rejection (GR) occurs in a significant proportion of individuals with transfusion-dependent β-thalassemia (TDT) following hematopoietic stem cell transplantation (HSCT). There have been limited data on the outcome and...
3.
Weeks C, Vuppala R, Gold M, Simon A, Jillella A, Cortes J, et al.
J Hematol
. 2025 Feb;
14(1):38-42.
PMID: 39935701
No abstract available.
4.
Lau C, DiTullio D, Wilhalme H, Bowles L, Moore T, De Oliveira S
J Hematol
. 2025 Feb;
14(1):1-13.
PMID: 39935700
Background: Pediatric hematopoietic stem cell transplant (pHSCT) patients are at risk for many life-threatening post-transplant complications, notably relapse, graft-versus-host disease (GvHD), and infection. Methods: This retrospective study reviewed 10 years...
5.
Idamakanti M, Ebaid A, Bijjam R, Bakhirev A, Mukkamalla S, Andritsos L
J Hematol
. 2025 Feb;
14(1):32-37.
PMID: 39935699
Mast cell leukemia (MCL) is a rare and aggressive form of systemic mastocytosis (SM) that commonly involves the bone. This often presents as osteoporosis with focal osteolytic lesions and pathological...
6.
Amaru R, Prchal J, Ganz T, Zhang X, Paton D, Carrasco M, et al.
J Hematol
. 2025 Feb;
14(1):20-25.
PMID: 39935698
Background: Bolivian Andean Aymara highlanders, living at 4,000 m for 14,000 years, have evolved genetic adaptations to hypoxia. These include encoding prolyl hydroxylase 2 (PHD2), a regulator of transferrin transcription....
7.
Verghese C, Brahmbhatt N, Ghous G, Meleveedu K, Vander Velde N, Hunter M, et al.
J Hematol
. 2024 Dec;
13(6):285-289.
PMID: 39697686
Immune checkpoint inhibitors (CPIs) can cause immune-related organ dysfunctions, including nephritis, pneumonitis, thyroiditis, hepatitis, colitis and more rarely hematological toxicities like immune-related autoimmune hemolytic anemia (irAIHA). Very few cases of...
8.
Hickmann K, Dileo R, Faringer K, Peterson C, Khan C, Samhouri Y
J Hematol
. 2024 Dec;
13(6):295-299.
PMID: 39697685
Chimeric antigen receptor (CAR) T-cell therapy has transformed treatment of refractory B-cell malignancies; however, treatment puts patients at risk for side effects secondary to the amplified immune response it induces....
9.
Chariyamane A, Randolph T
J Hematol
. 2024 Dec;
13(6):261-267.
PMID: 39697684
Background: Anemia is a global health issue that affects over 1 billion people and contributes to maternal mortality and birth defects. Low-resource, tropical areas face a dual challenge: high prevalence...
10.
Goto T, Hatano K, Kanemura N, Makita H, Goto H
J Hematol
. 2024 Dec;
13(6):290-294.
PMID: 39697683
Plasmablastic lymphoma (PBL) is a malignant lymphoma with poor prognosis that occurs in immunocompromised and elderly patients. We describe the case of a 75-year-old woman with PBL as a methotrexate-associated...